Respiratory System Drugs Practice Questions

Q: Ipratropium bromide, used in bronchial asthma, is classified as which of the following?

Anticholinergics. **Explanation:** **Ipratropium bromide** is a quaternary ammonium derivative of atropine. It acts as a **competitive antagonist at muscarinic receptors (M3)** located on bronchial smooth muscle. By blocking the action of acetylcholine released from parasympathetic nerve endings, it inhibits bronchoconstriction and reduces mucus secretion, leading to bronchodilation. **Analysis of Options:** * **A. Sympathomimetics:** These drugs (e.g., Salbutamol, Formoterol) stimulate $\beta_2$-adrenergic receptors to increase cAMP, causing bronchodilation. Ipratropium does not act on adrenergic receptors. * **B. Methylxanthines:** This class (e.g., Theophylline) works by inhibiting phosphodiesterase (PDE) enzymes and antagonizing adenosine receptors. * **D. Mast cell stabilizers:** Drugs like Sodium Cromoglycate prevent the degranulation of mast cells and the release of inflammatory mediators; they do not have direct bronchodilatory properties. **NEET-PG High-Yield Pearls:** 1. **Drug of Choice:** Ipratropium/Tiotropium are the **drugs of choice for COPD**. In bronchial asthma, they are typically used as add-on therapy to $\beta_2$-agonists (SABA). 2. **Pharmacokinetics:** Being a quaternary ammonium compound, Ipratropium is highly polar. It is poorly absorbed into the systemic circulation when inhaled, resulting in **minimal systemic side effects** (like tachycardia or urinary retention). 3. **Tiotropium vs. Ipratropium:** Tiotropium is long-acting (LAMA) due to slow dissociation from M3 receptors, allowing for once-daily dosing, whereas Ipratropium is short-acting (SAMA). 4. **Clinical Advantage:** Unlike atropine, Ipratropium does not significantly impair mucociliary clearance.

Q: Which of the following is a long-acting M3 antagonist used for bronchial asthma?

Tiotropium. **Explanation** **Tiotropium** is the correct answer because it is a **Long-Acting Muscarinic Antagonist (LAMA)**. It works by blocking M3 receptors on bronchial smooth muscle, leading to bronchodilation. Its clinical superiority lies in its kinetic selectivity: it dissociates very slowly from M3 and M1 receptors but rapidly from M2 receptors (which are pre-junctional autoreceptors that inhibit acetylcholine release). This results in a prolonged duration of action (over 24 hours), allowing for once-daily dosing via inhalation. **Analysis of Incorrect Options:** * **A. Ipratropium:** This is a **Short-Acting Muscarinic Antagonist (SAMA)**. It has a rapid onset but a short duration of action (4–6 hours), requiring frequent dosing. It is primarily used for acute relief or in COPD exacerbations. * **B. Glycopyrrolate:** While it is an anticholinergic, it is traditionally used as a pre-anesthetic medication to reduce secretions or to reverse neuromuscular blockade. Though newer inhaled formulations exist for COPD, Tiotropium remains the classic prototype for long-acting asthma/COPD management in exams. * **C. Cromoglycate:** This is a **Mast Cell Stabilizer**, not an anticholinergic. It prevents the release of inflammatory mediators but does not cause direct bronchodilation. **High-Yield Pearls for NEET-PG:** * **Drug of Choice:** LAMAs like Tiotropium are the drugs of choice for **COPD** maintenance. * **Side Effects:** The most common side effect of inhaled anticholinergics is **dry mouth** (xerostomia). * **Safety:** Unlike beta-2 agonists, anticholinergics do not cause skeletal muscle tremors or cardiac arrhythmias, making them safer in elderly patients with comorbidities. * **Mnemonic:** Remember **"Tio"** (Tiotropium) stays **"Longer"** than **"Ipra"** (Ipratropium).

Q: Which statement is not true regarding beclomethasone?

Effective in acute asthma. **Explanation:** Beclomethasone dipropionate is a potent **Inhaled Corticosteroid (ICS)** used as a first-line "controller" medication in the long-term management of bronchial asthma [4]. **Why Option C is the correct answer (False statement):** Corticosteroids, including beclomethasone, do not possess direct bronchodilatory properties [1], [2]. Their mechanism involves the modulation of gene expression (genomic effect) to reduce airway inflammation [2], which takes **hours to days** to manifest clinically [1]. Therefore, they are **ineffective in acute asthma attacks** (status asthmaticus), where rapid-acting bronchodilators like Salbutamol (SABA) are required [3]. **Analysis of other options:** * **Option A (True):** It is indicated for chronic use to reduce airway hyperreactivity and prevent exacerbations [1], [4]. * **Option B (True):** Beclomethasone is a classic example of an inhalational corticosteroid, designed to deliver high local concentrations to the lungs with minimal systemic absorption. * **Option D (True):** Local deposition of the drug in the oropharynx can suppress local immunity, predisposing patients to **Oropharyngeal Candidiasis** (Oral thrush) and hoarseness of voice (dysphonia). **High-Yield NEET-PG Pearls:** * **Prevention of Side Effects:** Patients should be advised to **rinse their mouth with water** and spit after each use to prevent fungal infections. * **Prodrug Status:** Beclomethasone dipropionate is a **prodrug** converted by esterases in the lungs to the active metabolite, beclomethasone-17-monopropionate. * **Ciclesonide:** Another ICS prodrug, often preferred because it is activated specifically by bronchial esterases, further reducing the risk of oral thrush.

Q: Inhibition of 5-lipoxygenase is useful in which of the following conditions?

Bronchial asthma. **Explanation:** The correct answer is **Bronchial asthma**. **Mechanism of Action:** The enzyme **5-lipoxygenase (5-LOX)** is responsible for the conversion of arachidonic acid into **leukotrienes** (LTC4, LTD4, and LTE4). These cysteinyl leukotrienes are potent bronchoconstrictors, increase vascular permeability (causing mucosal edema), and promote mucus secretion. By inhibiting 5-LOX, the drug **Zileuton** prevents the synthesis of these mediators, thereby reducing airway inflammation and bronchospasm in patients with asthma. **Analysis of Incorrect Options:** * **Cardiac failure:** Treatment focuses on reducing preload/afterload (ACE inhibitors, diuretics) and improving contractility. 5-LOX inhibitors have no established role in managing heart failure. * **Hepatic failure:** Management involves treating the underlying cause and complications (e.g., lactulose for encephalopathy). Zileuton is actually contraindicated in active liver disease due to potential hepatotoxicity. * **Arthritis:** While inflammation is a key component, the primary mediators in arthritis are prostaglandins (inhibited by COX-2 inhibitors) and TNF-alpha. 5-LOX inhibitors are not standard therapy for arthritis. **High-Yield Clinical Pearls for NEET-PG:** * **Zileuton** is the specific 5-LOX inhibitor to remember. * **Montelukast and Zafirlukast** are different; they are **Leukotriene Receptor Antagonists (LTRAs)** that block the CysLT1 receptor. * **Aspirin-Exacerbated Respiratory Disease (AERD):** Aspirin shunts arachidonic acid toward the LOX pathway, increasing leukotrienes. LTRAs and 5-LOX inhibitors are particularly effective in this condition. * **Side Effect:** Monitor Liver Function Tests (LFTs) when prescribing Zileuton.

Q: The release of histamine and leukotrienes from mast cells is prevented by which of the following drugs?

Nedocromil sodium. **Explanation:** The correct answer is **Nedocromil sodium**. This drug belongs to the class of **Mast Cell Stabilizers**. **1. Why Nedocromil sodium is correct:** Mast cell stabilizers (including Cromolyn sodium and Nedocromil) work by inhibiting the degranulation of sensitized mast cells. They prevent the release of various inflammatory mediators, such as **histamine, leukotrienes (LTs), and prostaglandins**, which are triggered by IgE-antigen interactions. They act by inhibiting chloride channels in the mast cell membrane, leading to hyperpolarization and prevention of calcium influx required for degranulation. **2. Why the other options are incorrect:** * **Zileuton:** This is a **5-Lipoxygenase (5-LOX) inhibitor**. It prevents the *synthesis* of leukotrienes from arachidonic acid but does not prevent the release of pre-formed histamine from mast cells. * **Zafirlukast:** This is a **Leukotriene Receptor Antagonist (LTRA)**. It blocks the $CysLT_1$ receptor. It does not prevent the release of mediators; it only blocks the action of leukotrienes at the receptor site. * **Fexofenadine:** This is a **second-generation $H_1$ antihistamine**. It blocks the action of histamine at the receptor level but does not stop the mast cell from releasing it. **High-Yield Clinical Pearls for NEET-PG:** * **Prophylaxis only:** Mast cell stabilizers are used for the *prevention* of bronchial asthma and exercise-induced bronchospasm. They are **ineffective** during an acute attack because they cannot reverse the action of mediators already released. * **Route:** They have poor oral absorption and are typically administered via inhalation (MDI/nebulizer). * **Nedocromil vs. Cromolyn:** Nedocromil is generally considered more potent and may also inhibit the activation of other inflammatory cells like eosinophils and neutrophils.

Q: Leukotriene inhibitors are very effective in which one of the following conditions?

Aspirin-induced asthma. **Explanation:** **1. Why Aspirin-induced asthma (AIA) is the correct answer:** Aspirin and other NSAIDs inhibit the enzyme **Cyclooxygenase (COX)**. This inhibition shifts the metabolism of arachidonic acid away from the prostaglandin pathway and toward the **Lipoxygenase (LOX) pathway**. This results in an overproduction of **Cysteinyl Leukotrienes (LTC4, LTD4, LTE4)**, which are potent bronchoconstrictors. Since the pathophysiology of AIA is directly driven by leukotriene excess, Leukotriene Receptor Antagonists (LTRAs) like **Montelukast** and **Zafirlukast** are specifically effective and considered the drugs of choice for managing this condition (Samter’s Triad). **2. Why other options are incorrect:** * **Exercise-induced asthma:** While LTRAs are used for prophylaxis, the primary mechanism involves heat and moisture loss from the airways. Short-acting beta-agonists (SABA) are generally more effective for immediate prevention. * **Antigen-induced asthma:** This is primarily an IgE-mediated Type I hypersensitivity reaction. While leukotrienes are involved, inhaled corticosteroids (ICS) are the mainstay of treatment to control the underlying inflammation. * **Occupational asthma:** This is triggered by specific workplace sensitizers. The most effective management is the removal of the inciting agent; LTRAs are only adjunctive therapy. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Montelukast and Zafirlukast are selective antagonists at the **CysLT1 receptor**. * **Zileuton:** A 5-Lipoxygenase (5-LOX) inhibitor; it is less commonly used due to potential hepatotoxicity. * **Churg-Strauss Syndrome:** A rare but high-yield side effect (eosinophilic granulomatosis with polyangiitis) associated with the use of LTRAs. * **Aspirin Triad (Samter’s Triad):** Consists of Asthma, Aspirin sensitivity, and Nasal polyps.

Q: All of the following are used in the management of bronchial asthma, except:

Morphine. **Explanation:** The correct answer is **Morphine**. In fact, Morphine is strictly **contraindicated** in bronchial asthma. **Why Morphine is the correct answer (Contraindication):** Morphine, an opioid analgesic, is dangerous in asthmatic patients for two primary reasons: 1. **Histamine Release:** Morphine triggers the non-immunologic release of histamine from mast cells, which leads to potent bronchoconstriction and increased mucus secretion, worsening the airway obstruction. 2. **Respiratory Depression:** It acts on the medulla to decrease the sensitivity of the respiratory center to $CO_2$, leading to respiratory depression, which can be fatal during an acute asthma exacerbation. **Why the other options are incorrect:** * **Salbutamol:** A Short-Acting Beta-2 Agonist (SABA). it is the drug of choice for relieving acute bronchospasm by increasing cAMP levels, leading to smooth muscle relaxation. * **Aminophylline:** A methylxanthine (theophylline derivative) that acts by inhibiting phosphodiesterase (PDE) and antagonizing adenosine receptors, resulting in bronchodilation. * **Steroids (Corticosteroids):** These are the mainstay of long-term management. They reduce airway inflammation, decrease mucosal edema, and upregulate beta-2 receptors. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (Acute Attack):** Inhaled SABA (Salbutamol/Albuterol). * **Drug of Choice (Prophylaxis/Maintenance):** Inhaled Corticosteroids (ICS) like Fluticasone or Budesonide. * **Morphine in Cardiac Asthma:** While contraindicated in bronchial asthma, Morphine is used in **Cardiac Asthma** (secondary to Left Ventricular Failure) because it reduces preload and relieves pulmonary congestion. * **Safe Opioid:** If an opioid is absolutely necessary in an asthmatic patient, **Fentanyl** is preferred as it does not cause histamine release.

Q: What is the mechanism of action of Salmeterol?

Pure beta-2 agonist. **Explanation:** **Salmeterol** is a Long-Acting Beta-2 Agonist (LABA) used primarily in the maintenance treatment of asthma and COPD. Its mechanism of action involves the selective stimulation of **Beta-2 receptors** located on the bronchial smooth muscle. This stimulation activates the enzyme adenylyl cyclase, increasing intracellular cyclic AMP (cAMP), which leads to powerful bronchodilation. **Why Option A is Correct:** Salmeterol is classified as a **selective (pure) Beta-2 agonist**. Unlike short-acting agents (SABA) like Salbutamol, Salmeterol has a long lipophilic side chain that anchors it to the receptor site, providing a prolonged duration of action (approx. 12 hours). **Why Other Options are Incorrect:** * **Option B & C:** Beta-1 receptors are primarily located in the heart. Stimulation causes increased heart rate (tachycardia) and contractility. While selectivity is lost at very high doses, Salmeterol is designed to avoid Beta-1 activation to minimize cardiac side effects. * **Option D:** Alpha-1 agonists cause vasoconstriction and are used as nasal decongestants (e.g., Oxymetazoline) or to raise blood pressure, not for bronchodilation. **High-Yield Clinical Pearls for NEET-PG:** * **Onset vs. Duration:** Salmeterol has a **slow onset of action**; therefore, it is never used for acute asthma attacks (Rescue therapy). It is for maintenance only. * **Black Box Warning:** LABAs should **never be used as monotherapy** in asthma due to the risk of asthma-related death. They must always be combined with an Inhaled Corticosteroid (ICS). * **Side Effects:** Fine tremors (skeletal muscle Beta-2 stimulation), tachycardia (reflex or Beta-1 crossover), and hypokalemia.

Q: Which of the following expectorants causes gastric irritation and a reflex increase in bronchial gland secretions?

Guaifenesin. ### Explanation **Correct Option: B. Guaifenesin** Guaifenesin is a classic **secretolytic expectorant**. Its primary mechanism of action involves **gastric irritation**, which stimulates the vagal afferent nerves in the stomach lining. This triggers a **reflex increase in bronchial gland secretions** (efferent parasympathetic response). By increasing the volume and decreasing the viscosity of respiratory tract fluid, it makes the mucus thinner and easier to expel via coughing. **Analysis of Incorrect Options:** * **A. Ambroxol:** This is a **mucolytic** agent (a metabolite of Bromhexine). It works by breaking down the acid mucopolysaccharide fibers in the sputum and stimulating surfactant production. It does not primarily act via the gastric reflex mechanism. * **C. Sodium cromoglycate:** This is a **mast cell stabilizer** used in the prophylaxis of bronchial asthma. It prevents the degranulation of mast cells and the release of inflammatory mediators like histamine. It has no expectorant properties. * **D. Fosaprepitant:** This is a **Neurokinin-1 (NK1) receptor antagonist** used as an antiemetic, specifically for chemotherapy-induced nausea and vomiting (CINV). It has no role in the respiratory system. **High-Yield NEET-PG Pearls:** * **Classification of Expectorants:** 1. **Directly acting:** Volatile oils (e.g., Eucalyptus oil), Potassium iodide (secreted by bronchial glands). 2. **Reflexly acting:** Guaifenesin, Ammonium salts, Sodium/Potassium citrate. * **Mucolytics vs. Expectorants:** Mucolytics (Acetylcysteine, Carbocisteine, Bromhexine) chemically alter the mucus structure, whereas expectorants increase the volume of secretion to facilitate removal. * **Acetylcysteine:** Acts by breaking **disulfide bonds** in mucoproteins; it is also the specific antidote for **Paracetamol (Acetaminophen) poisoning**.

Question 1

A 25-year-old man experiences exercise-induced bronchospasm, particularly in cold weather. He takes a medication 15 minutes prior to anticipated exercise which helps prevent asthmatic attacks but does not produce bronchodilation. Which drug does he take?

Accepted Answer

Cromolyn sodium

Answer

Short-acting beta-agonist inhaler

Answer

Inhaled glucocorticoid

Answer

Omalizumab

Question 2

Ipratropium bromide, used in bronchial asthma, is classified as which of the following?

Accepted Answer

Anticholinergics

Answer

Sympathomimetics

Answer

Methylxanthines

Answer

Mast cell stabilizers

Question 3

Which of the following is a long-acting M3 antagonist used for bronchial asthma?

Accepted Answer

Tiotropium

Answer

Ipratropium

Answer

Glycopyrolate

Answer

Cromoglycate

Question 4

Which statement is not true regarding beclomethasone?

Accepted Answer

Effective in acute asthma

Answer

Indicated for chronic use

Answer

An inhalational corticosteroid

Answer

Predisposes to fungal infections

Question 5

Inhibition of 5-lipoxygenase is useful in which of the following conditions?

Accepted Answer

Bronchial asthma

Answer

Cardiac failure

Answer

Hepatic failure

Answer

Arthritis

Question 6

The release of histamine and leukotrienes from mast cells is prevented by which of the following drugs?

Accepted Answer

Nedocromil sodium

Answer

Zileuton

Answer

Zafirlukast

Answer

Fexofenadine

Question 7

Leukotriene inhibitors are very effective in which one of the following conditions?

Accepted Answer

Aspirin-induced asthma

Answer

Exercise-induced asthma

Answer

Antigen-induced asthma

Answer

Occupational asthma

Question 8

All of the following are used in the management of bronchial asthma, except:

Accepted Answer

Morphine

Answer

Salbutamol

Answer

Aminophylline

Answer

Steroids

Question 9

What is the mechanism of action of Salmeterol?

Accepted Answer

Pure beta-2 agonist

Answer

Pure beta-1 agonist

Answer

Beta-1 and Beta-2 agonist

Answer

Alpha-1 agonist

Question 10

Which of the following expectorants causes gastric irritation and a reflex increase in bronchial gland secretions?

Accepted Answer

Guaifenesin

Answer

Ambroxol

Answer

Sodium cromoglycate

Answer

Fosaprepitant

Respiratory System Drugs — MCQs

Respiratory System Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?